Laboratory of Molecular Biology of Bacterial Pathogens, Institute of Microbiology of the Academy of Sciences of the Czech Republic, CZ-142 20 Prague 4, Czech Republic,1
Unité de Biologie des Régulations Immunitaires, Institut Pasteur, 75724 Paris, France2
Received 20 June 2001/
Returned for modification 7 August 2001/
Accepted 6 November 2001
This work was supported by ANRS and by grants no. 310/01/0934, A502907, and ME167 of the Grant Agency, the Academy of Science, and the Ministry of Education, Youth, and Sports of the Czech Republic, respectively, and QLK2-CT-1999-00556 from the 5th Framework Program of the European Union.
| 1. |
Dadaglio, G., Z. Moukrim, R. Lo-Man, V. Sheshko, P. Sebo, and C. Leclerc. 2000. Induction of a polarized Th1 response by insertion of multiple copies of a viral T-cell epitope into adenylate cyclase of Bordetella pertussis. Infect. Immun. 68:3867-3872.[Abstract/Free Full Text] |
| 2. |
Fayolle, C., D. Ladant, G. Karimova, A. Ullmann, and C. Leclerc. 1999. Therapy of murine tumors with recombinant Bordetella pertussis adenylate cyclase toxins carrying a cytotoxic T-cell epitope. J. Immunol. 162:4157-4162.[Abstract/Free Full Text] |
| 3. |
Fayolle, C., A. Osickova, R. Osicka, T. Henry, M.-J. Rojas, M.-F. Saron, P. Sebo, and C. Leclerc. 2001. Delivery of multiple epitopes by recombinant detoxified adenylate cyclase of Bordetella pertussis induces protective antiviral immunity. J. Virol. 75:7330-7338.[Abstract/Free Full Text] |
| 4. |
Fayolle, C., P. Sebo, D. Ladant, A. Ullmann, and C. Leclerc. 1996. In vivo induction of CTL responses by recombinant adenylate cyclase of Bordetella pertussis carrying viral CD8+ T cell epitopes. J. Immunol. 156:4697-4706.[Abstract] |
| 5. |
Guermonprez, P., C. Fayolle, G. Karimova, A. Ullmann, C. Leclerc, and D. Ladant. 2000. Bordetella pertussis adenylate cyclase toxin: a vehicle to deliver CD8-positive T-cell epitopes into antigen-presenting cells. Methods Enzymol. 326:527-542.[Medline] |
| 6. |
Guermonprez, P., N. Khelef, E. Blouin, P. Rieu, P. Ricciardi-Castagnoli, N. Guiso, D. Ladant, and C. Leclerc. 2001. The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the Mß2 integrin (CD11b/CD18). J. Exp. Med. 193:1035-1044.[Abstract/Free Full Text] |
| 7. |
Guermonprez, P., D. Ladant, G. Karimova, A. Ullmann, and C. Leclerc. 1999. Direct delivery of the Bordetella pertussis adenylate cyclase toxin to the MHC class I antigen presentation pathway. J. Immunol. 162:1910-1916.[Abstract/Free Full Text] |
| 8. |
Karimova, G., C. Fayolle, S. Gmira, A. Ullmann, C. Leclerc, and C. Ladant. 1998. Charge-dependent translocation of Bordetella pertussis adenylate cyclase toxin into eukaryotic cells: implication for the in vivo delivery of CD8+ T cell epitopes into antigen-presenting cells. Proc. Natl. Acad. Sci. USA 95:12532-12537.[Abstract/Free Full Text] |
| 9. |
Kern, D. E., J. P. Klarnet, M. C. Jensen, and P. D. Greenberg. 1986. Requirement for recognition of class II molecules and processed tumor antigen for optimal generation of syngeneic tumor-specific class I-restricted CTL. J. Immunol. 136:4303-4310.[Abstract] |
| 10. |
Ladant, D., and A. Ullmann. 1999. Bordetella pertussis adenylate cyclase: a toxin with multiple talents. Trends Microbiol. 7:172-176.[CrossRef][Medline] |
| 11. |
Lo-Man, R., J. P. M. Langeveld, E. Dériaud, M. Jehanno, M. Rojas, J. M. Clément, R. H. Meloen, M. Hofnung, and C. Leclerc. 2000. Extending the CD4+ T-cell epitope specificity of the Th1 immune response to an antigen using a Salmonella enterica serovar Typhimurium delivery vehicle. Infect. Immun. 68:3079-3089.[Abstract/Free Full Text] |
| 12. |
Osi ka, R., A. Osi kova, T. Basar, P. Guermonprez, M. Rojas, C. Leclerc, and P. ebo. 2000. Delivery of CD8+ T-cell epitopes into major histocompatibility complex class I antigen presentation poathway by Bordetella pertussis adenylate cyclase: delineation of cell invasive structures and permissive insertion sites. Infect. Immun. 68:247-256.[Abstract/Free Full Text] |
| 13. |
Saron, M. F., C. Fayolle, P. Sebo, D. Ladant, A. Ullmann, and C. Leclerc. 1997. Anti-viral protection conferred by recombinant adenylate cyclase toxins from Bordetella pertussis carrying a CD8+ T cell epitope from lymphocytic choriomeningitis virus. Proc. Natl. Acad. Sci. USA 94:3314-3319.[Abstract/Free Full Text] |
| 14. |
Schnell, S., J. W. Young, A. N. Houghton, and M. Sadelain. 2000. Retrovirally transduced mouse dendritic cells require CD4+ T cell help to elicit antitumor immunity: implications for the clinical use of dendritic cells. J. Immunol. 164:1243-1250.[Abstract/Free Full Text] |
| 15. |
ebo, P., C. Fayolle, O. d'Andria, D. Ladant, C. Leclerc, and A. Ullmann. 1995. Cell-invasive activity of epitope-tagged adenylate cyclase of Bordetella pertussis allows in vitro presentation of a foreign epitope to CD8+ cytotoxic T cells. Infect. Immun. 63:3851-3857.[Abstract] |
| 16. |
Sebo, P., Z. Moukrim, M. Kalhous, N. Schaft, G. Dadaglio, V. Sheshko, C. Fayolle, and C. Leclerc. 1999. In vivo induction of CTL responses by recombinant adenylate cyclase of Bordetella pertussis carrying multiple copies of a viral CD8+ T-cell epitope. FEMS Immunol. Med. Microbiol. 26:167-173.[CrossRef][Medline] |
| 17. |
Toes, R. E., F. Ossendorp, R. Offringa, and C. J. Melief. 1999. CD4+ T cells and their role in antitumor immune responsesJ. Exp. Med. 189:753-756.[Free Full Text] |